Yusuf Henriques

Yusuf Henriques has a diverse work experience in the fields of healthcare, technology, and entrepreneurship. Yusuf is currently a Fellow at MedTechVets since 2023, where they are gaining valuable skills and knowledge in the medical technology industry. Before that, Yusuf founded and served as the CEO of IndyGeneUS AI from 2021 to present, demonstrating their entrepreneurial drive and leadership abilities.

Yusuf is also a Co-Founder of the ALIVE Podcast Network since 2022, a platform that combines education, entertainment, and e-commerce through podcasting. Prior to that, they held the position of Senior Vice President at Everything Landmark starting in 2020, showcasing their experience in a senior-level role.

In 2020, Yusuf worked as a Principal Consultant at K3MH Regulatory Science & Strategy, where they provided expert advice in regulatory affairs. Yusuf also served as a Boston Techstars Mentor-in-Residence at Techstars, supporting and guiding emerging startup companies in the Boston area.

Additionally, Yusuf has held important roles in the healthcare industry. Yusuf was a Health Transformer at StartUp Health in 2023, contributing to innovation and transformation in the healthcare sector. Yusuf also became an Advisory Board Member at Pharma IQ in 2022, where they shared their expertise and insights.

Yusuf'sinvolvement with wePool Inc. as a Board Member-Chief Strategy Officer (CSO) since 2020 highlights their strategic thinking and decision-making abilities. Yusuf's previous role as the Founder & CEO of IndyGeneUS Health from 2021 to 2022 demonstrates their entrepreneurial spirit in the healthcare sector.

Overall, Yusuf Henriques' work experience showcases their expertise in healthcare, technology, and entrepreneurship, highlighting their leadership skills, strategic thinking, and commitment to innovation.

Yusuf Henriques has a Bachelor of Science (BS) degree in Biochemistry from Howard University. Yusuf is currently a candidate for a Master of Public Health (MPH) degree, specializing in Risk Science and Policy, at the Johns Hopkins Bloomberg School of Public Health.